Biosyent Inc
- LAST PRICE8.4000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 8.4000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RX |
|---|---|---|
| 09:38 ET | 100 | 8.5 |
| 09:48 ET | 1200 | 8.5 |
| 10:42 ET | 400 | 8.5 |
| 11:29 ET | 600 | 8.4 |
| 12:48 ET | 100 | 8.48 |
| 03:32 ET | 100 | 8.4 |
Apr 15, 2024
BioSyent Announces Extension of RepaGyn(R) and Proktis-M(R) Agreement, from 4:31PM ET on Monday Apr 15, 2024 by Dow Jones
4:31PM ET on Monday Apr 15, 2024 by Dow Jones
Apr 10, 2024
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference, from 8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 3, 2024
FeraMAX(R) Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year, from 8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 03, 2024 by Dow Jones
Apr 1, 2024
BioSyent to Present at LD Micro New York Investor Conference, from 2:00PM ET on Monday Apr 01, 2024 by Dow Jones
2:00PM ET on Monday Apr 01, 2024 by Dow Jones
Mar 27, 2024
BioSyent Announces Grant of Restricted Share Units, from 6:34PM ET on Wednesday Mar 27, 2024 by Dow Jones
6:34PM ET on Wednesday Mar 27, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Biosyent Inc | 98.8M | 15.8x | +6.22% |
Innocan Pharma Corp | 78.4M | -11.4x | --- |
1CM Inc | 117.7M | -69.0x | --- |
Spectral Medical Inc | 122.6M | -7.9x | --- |
BellRock Brands Inc | 48.9M | -0.6x | --- |
Medicus Pharma Ltd | 36.2M | -2.2x | --- |
Company Information
BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing biologically and health friendly non-chemical insecticides. Its products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn, and Tibella. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. Cathejell combines sterile gel and 2% lidocaine jelly in a collapsible syringe that is ready to use. FeraMAX Pd Therapeutic 150 is an oral hematinic that helps the body form red blood cells and is indicated for the treatment of iron deficiency anemia.
Contact Information
- Headquarters
- 2476 Argentia Road, Suite 402MISSISSAUGA, ON, Canada L5N 6M1
- Phone
- 905-206-0013
- Fax
- 905-206-1413
Executives
- Chairman of the Board, President, Chief Executive Officer
- Rene Goehrum
- Vice President, Corporate Development
- Robert March
- Vice President- Corporate Development
- Joost Van Der Mark
- Vice President - Community Health Business
- Kevin Wilson
- Director - Human Resources
- Neelu Atwal
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $98.8M |
|---|---|
Revenue (TTM) | $31.6M |
Shares Outstanding | 11.8M |
Dividend Yield | 2.14% |
Annual Dividend Rate | 0.1800 CAD |
Ex-Dividend Date | 02-28-24 |
Pay Date | 03-15-24 |
Beta | 0.93 |
EPS | $0.53 |
Book Value | $2.96 |
P/E Ratio | 15.8x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 14.3x |
Operating Margin | 23.65% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
